Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance

Citations Over TimeTop 1% of 2018 papers

Abstract

Chemotherapy is still a main option for cancer therapy, but its efficacy is often unsatisfying due to multidrug resistance (MDR). The tumor microenvironment is considered a dominant factor causing MDR. Stimuli-responsive nanomedicines exhibit many superiorities for reversal of MDR. As smart systems, stimuli-responsive nanomedicines are desirable for achieving site-specific accumulation and triggered drug release in response to slight changes in physicochemical properties in pathological conditions or to exogenous stimuli. In this review, we highlight the current progress of various nanomedicines with different stimuli-responsive capabilities for overcoming MDR. The materials, design, construction as well as efficacy in overcoming MDR of these nanomedicines are discussed. Eventually, we look forward to forthcoming intelligent nanoparticle systems with new mechanisms to deliver drugs for practical applications in conquering cancer MDR.

Related Papers

• → Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement(2018)327 cited
• → Cancer nanomedicine: is targeting our target?(2016)227 cited
• → Image-Guided Cancer Nanomedicine(2018)31 cited
• → Nanomedicine: Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines (Adv. Healthcare Mater. 1/2018)(2018)7 cited
• → NANOMEDICINE—PRESENT AND FUTURE OF DISEASE MANAGEMENT(2022)